Arian Investment has increased its holdings in Bliss GVS Pharma and now aggregating to more than five percent of the shares of the company Bliss GVS. Arian Investment’s holding in the company now stands at 9.22%.
Bliss GVS Pharma is a fast-growing Pharmaceutical Company with a proven track record of developing, manufacturing and marketing high quality pharmaceutical formulations at affordable prices for the global market.